Nephros (NEPH) Change in Receivables (2010 - 2026)
Nephros (NEPH) posted quarterly Change in Receivables of $1.1 million for Q1 2026, up 23.55% year-over-year from $896000.0 in Q1 2025, and up 548.18% quarter-over-quarter from -$247000.0 in Q4 2025.
Nephros (NEPH) Change in Receivables (2010 - 2026) Analysis & Trends
Nephros' Change in Receivables history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 23.55% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $844000.0 (down 27.18% YoY), while the FY2025 annual figure was $633000.0, up 122.11% from the prior year.
- Change in Receivables for Q1 2026 stood at $1.1 million, up from -$247000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.1 million in Q1 2026, with the low at -$756000.0 in Q3 2022.
- The 5-year median for Change in Receivables is $22000.0 (2024), against an average of $111117.6.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables plunged 539.53% in 2022, then soared 3972.73% in 2025.
- Nephros' Change in Receivables stood at -$88000.0 in 2022, then jumped by 156.82% to $50000.0 in 2023, then soared by 80.0% to $90000.0 in 2024, then sank by 374.44% to -$247000.0 in 2025, then surged by 548.18% to $1.1 million in 2026.
- Business Quant data shows NEPH's Change in Receivables at $1.1 million in Q1 2026, -$247000.0 in Q4 2025, and $621000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.62 Bn | 51.76 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.68 Bn | 32.21 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.26 Bn | 26.59 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.42 Bn | 15.02 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.52 Bn | 11.37 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Nephros | 43.75 Mn | 39.05 Mn | 4.03 Mn | 577,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 577,000.00 |
| Jun 30, 2026 | 577,000.00 |
| Mar 31, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | -247,000.00 |
| Dec 31, 2025 | -247,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | -637,000.00 |
| Jun 30, 2025 | -637,000.00 |
| Mar 31, 2025 | 896,000.00 |
| Mar 31, 2025 | 896,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | -187,000.00 |
| Sep 30, 2024 | -187,000.00 |
| Jun 30, 2024 | 360,000.00 |
| Jun 30, 2024 | 360,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |